Robert B. Ford - Sep 12, 2024 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
CHAIRMAN AND CEO, Director
Signature
/s/ Robert B. Ford by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Sep 12, 2024
Transactions value $
-$9,807,243
Form type
4
Date filed
9/13/2024, 05:24 PM
Previous filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $5.99M +127K +57.91% $47.00 347K Sep 12, 2024 Direct
transaction ABT Common shares without par value Options Exercise $696K +14.2K +4.1% $48.90 362K Sep 12, 2024 Direct
transaction ABT Common shares without par value Sale -$9.32M -80.3K -22.2% $116.04 281K Sep 12, 2024 Direct F1
transaction ABT Common shares without par value Sale -$7.18M -61.4K -21.81% $116.90 220K Sep 12, 2024 Direct F2
holding ABT Common shares without par value 197K Sep 12, 2024 Ford Family Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -127K -100% $0.00 0 Sep 12, 2024 Common Shares 127K $47.00 Direct F4
transaction ABT Option (right to buy) Options Exercise $0 -14.2K -100% $0.00 0 Sep 12, 2024 Common Shares 14.2K $48.90 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.58 to $116.54, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.58 to $117.29, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 Held in the Ford Family Trust DTD June 2, 2014. The reporting person is co-trustee of the trust.
F4 Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.